Mazen M Dimachkie MD
(Dr. Dimachkie, Director of the Neuromuscular Disease Division and Executive Vice Chairman for Research Programs, Department of Neurology, The University of Kansas Medical Center, received honorariums from Baxalta, Catalyst, CSL Behring, Mallinckrodt, Novartis, NuFactor, and Terumo for speaking engagements or consulting work, and grants from Alexion, Biomarin, Catalyst, CSL-Behring, FDA/OPD, GSK, MDA, NIH, Novartis, and Orphazyme.)
Randolph W Evans MD
, editor. (Dr. Evans received honorariums from Allergan, Amgen, Avanir, DepoMed, and Novartis for speaking engagements and honorariums from Alder, Amgen, Lilly, Novartis, and Promius for advisory board membership.)
Originally released July 14, 1999; last updated August 15, 2017; expires August 15, 2020
This article includes discussion of tibial nerve injuries and Morton neuroma. The foregoing terms may include synonyms, similar disorders, variations in usage, and abbreviations.
The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.
If you are a subscriber, please log in.
If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.
If you have never registered before, click Learn More about MedLink Neurology or view available Service Plans.